Global Fusion Biopsy Market to Register Sustainable Growth at a CAGR of ~6% by 2034 | DelveInsight
New York, USA, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Global Fusion Biopsy Market to Register Sustainable Growth at a CAGR of ~6% by 2034 | DelveInsight
The fusion biopsy market is witnessing strong growth due to the rising prevalence of prostate cancer and increasing adoption of MRI-ultrasound fusion technology for accurate diagnosis. Growing awareness of early cancer detection, coupled with advancements in imaging systems and biopsy guidance platforms, is driving demand for fusion biopsy procedures. Favorable reimbursement policies and expanding healthcare infrastructure are further supporting market expansion, particularly in North America and Europe. Additionally, the increasing shift toward minimally invasive, precision-guided diagnostic techniques is expected to sustain the market's growth over the coming years.
DelveInsight’s Fusion Biopsy Market Insights report provides the current and forecast market analysis, individual leading fusion biopsy companies’ market shares, challenges, fusion biopsy market drivers, barriers, trends, and key fusion biopsy companies in the market.
Fusion Biopsy Market Summary
To read more about the latest highlights related to the fusion biopsy market, get a snapshot of the key highlights @ https://www.delveinsight.com/report-store/fusion-biopsy-market
Key Factors Contributing to the Rise in Growth of the Fusion Biopsy Market
Get a sneak peek at the fusion biopsy market dynamics @ Fusion Biopsy Market Trends
Regional Fusion Biopsy Market Insights
North America
Europe
Asia-Pacific
To know more about why North America is leading the market growth in the fusion biopsy market, get a snapshot of the Fusion Biopsy Market Share
Recent Developmental Activities in the Fusion Biopsy Market
What is Fusion Biopsy?
Fusion biopsy is an advanced diagnostic procedure that combines real-time ultrasound imaging with previously acquired magnetic resonance imaging (MRI) scans to improve the accuracy of tissue sampling, particularly for prostate cancer detection. During the procedure, specialized software fuses detailed MRI images, which identify suspicious lesions, with live ultrasound guidance, enabling clinicians to precisely target areas that may harbor clinically significant cancer. Compared with conventional systematic biopsy, fusion biopsy increases the detection of aggressive tumors while reducing the likelihood of identifying low-risk cancers that may not require immediate treatment. This minimally invasive technique enhances diagnostic confidence, supports more personalized treatment decisions, and has become an increasingly preferred approach for patients with elevated prostate-specific antigen (PSA) levels, abnormal digital rectal examination findings, or suspicious lesions detected on multiparametric MRI.
Fusion Biopsy Market Assessment
Which MedTech key players in the fusion biopsy market are set to emerge as the trendsetter explore @ Fusion Biopsy Market Analysis
Table of Contents
Interested in knowing the fusion biopsy market share by 2034? Click to get a snapshot of the Fusion Biopsy Market Size
Related Reports
Biopsy Devices Market
Biopsy Devices Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key biopsy devices companies, including Boston Scientific Corporation, Cardinal Health, Medtronic, BD, Cook, Devicor Medical Products Inc., B. Braun Melsungen AG, ARGON MEDICAL, OLYMPUS CORPORATION, FUJIFILM, INRAD Inc., Hologic Inc., C. R. Bard, Dr. Japan Co Ltd., Limaca-medical, Owlstone Medical Ltd., Zamar Care, KOELIS, ST. STONE MEDICAL DEVICES PVT LTD, Iscon Surgicals Ltd., and others.
Digital Biopsy Market
Digital Biopsy Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key digital biopsy companies, including DermaSensor, Inc., SciBase, VITA IMAGING, Inc., MetaOptima Technology Inc., VPIX Medical Inc., Mauna Kea Technologies, Skin Analytics, Trafita Medical System, BRAINSPEC, Imaging Biometrics, LLC, Optovibronex, LLC, FUJIFILM Holdings Corporation, Canon Inc., VivaScope GmbH, and others.
Magnetic Resonance Imaging Devices Market
Magnetic Resonance Imaging Devices Market Insights, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key MRI devices companies, including General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Aspect Imaging Ltd., Bruker Corporation, Aurora Healthcare US Corp., FONAR Corp., Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., Time Medical Holding, Hyperfine, Alltech Medical Systems, InnerVision MRI Ltd., Magnetica Limited, IMRIS, Deerfield Imaging, Inc., and others.
AI in Ultrasound Imaging Market
AI in Ultrasound Imaging Market Insight, Competitive Landscape, and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key AI in ultrasound imaging companies, including GE HealthCare Technologies Inc., Koninklijke Philips N.V., Siemens Healthineers AG, Canon Medical Systems Corporation, Samsung Medison Co., Ltd., FUJIFILM Holdings Corporation, Butterfly Network, Inc., Mindray Medical International Limited, Exo Imaging, Inc., Clarius Mobile Health Corp., and others.
Prostate Cancer Market
Prostate Cancer Market Insights, Epidemiology, and Market Forecast – 2036 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key prostate cancer companies including Janssen Research and Development, Sanofi, AstraZeneca, Merck, Pfizer, Astellas Pharma, Bayer, Novartis, Curium, Merck, Orion, Janssen Pharmaceutical, Pfizer, Exelixis, Ipsen Pharma, Takeda, AB Science, Lantheus, Eli Lilly, POINT Biopharma, Telix Pharmaceuticals, Tavanta Therapeutics, Jiangsu Hengrui Pharmaceuticals, Kangpu Biopharmaceuticals, Fusion Pharma, Merus, Bristol-Myers Squibb, Syntrix Pharmaceuticals, Promontory Therapeutics, Xencor, Taiho Pharmaceutical, Madison Vaccines, MacroGenics, Zenith Epigenetics, Modra Pharmaceuticals, Arvinas, Laekna Therapeutics, Blue Earth Therapeutics, Oncternal Therapeutics, Essa Pharma, Clarity Pharmaceuticals, BioNTech, DualityBio, Daiichi Sankyo, Fortis Therapeutics, ORIC Pharmaceuticals, Amgen, and others.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.